Telehealth firms block obesity drug access, patients frustrated
#Telehealth #ObesityDrugsTelehealth companies like Vida Health now gatekeep GLP-1 drugs for employers, requiring patients to meet extra lifestyle program rules before obtaining coverage, often causing frustration and treatment delays despite primary care prescriptions. read more
Insurance Cuts Off Weight-Loss Drugs, Patients Scramble
#ObesityDrugs #InsuranceCoverageInsurance coverage for GLP-1 obesity drugs like Wegovy and Zepbound is declining, forcing patients to pay high out-of-pocket costs or switch medications. Many face restrictive policies, leaving them to navigate financial and medical uncertainty alone. read more